Search Results 11-20 of 17067 for Albinism

  1. Rhabdomyosarcoma - Doctors and departments - Mayo Clinic

    This rare soft tissue cancer affects children more often than adults. Treatment may include surgery, chemotherapy and radiation therapy.

  2. A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    For Cohort - II only: Participants with depigmenting or hypopigmenting conditions (e.g. albinism vitiligo) or active / history of chronic urticarial in the past ...

  3. DAYBREAK: Phase 2 Study in Patients With Specific Gene Defects in the MC4R Pathway - Mayo Clinic

    History or close family history (parents or siblings) of melanoma, or patient history of oculocutaneous albinism. Note: If the type of skin cancer is not ...

  4. A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    Participants with depigmenting or hypopigmenting conditions (e.g. albinism vitiligo) or active / history of chronic urticarial in the past year. More ...

  5. A Study to Evaluate Setmelanoitide to Treat Patients with Rare Genetic Disorders of Obesity - Mayo Clinic

    ... albinism. Significant dermatologic findings relating to melanoma or pre-melanoma skin lesions (excluding non-invasive basal or squamous cell lesion) ...

  6. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  7. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    Clinically relevant depigmenting or hypopigmenting conditions (e.g. albinism, vitiligo) or active / history of chronic urticaria in the past year. More ...

  8. Bardet-Biedl syndrome (BBS) - Symptoms and causes - Mayo Clinic

    This rare genetic condition causes weight gain, extra fingers or toes, kidney conditions, vision loss, and changes in development.

  9. A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease

    Clinically relevant depigmenting or hypopigmenting conditions (e.g. albinism, vitiligo) or active / history of chronic urticaria in the past year.

  10. Insights into IBD genetics - Mayo Clinic

    An error occurred, please try again later. Copy for customer care: session ID undefined. Try again. Share · Tweet . VID-20538381.